AUS
NZ
UK
CA
USA
IND
Healthcare
AnteoTech's impressive performance in the first half of FY2025 paves the way for future growth.
February 27, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,AnteoTech reports a 74% increase in revenue driven by strategic commercial initiatives.,Significant progress noted in Clean Energy and Life Sciences sectors, with key partnerships enhancing growth.,The company's financial strategies includ...
Neuren Shares See Half-Price Discount as Brokers Sound the Alarm
February 27, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Neuren Pharmaceuticals (ASX:NEU) sees potential leveraged growth for its Rett syndrome drug, Daybue.,February's biotech sector downturn offers opportunities for investment research as major stocks face price corrections.,Dimerix (ASX:DXB)...
What's Happening with Actinogen’s Xanamem in 2025?
February 27, 2025 10:30 AM AEDT| By Team Kalkine MediaHighlights,The biotechnology sector is driving advancements in neurological disorder treatments, with a focus on Alzheimer’s disease.,Actinogen Medical has received an international non-proprietary name for Xanamem, marking a key regulatory milestone...
Nanosonics Limited Reports Strong Earnings and Cash Flow Performance
February 26, 2025 07:31 PM AEDT| By Team Kalkine MediaHighlights:,Nanosonics Limited demonstrates strong earnings growth in its latest financial update.,The company’s free cash flow surpasses reported profits, reflecting efficient cash management.,Earnings per share have shown significant improvement ov...
If the Liberals secure victory in the WA election, anticipate significant changes in the mining sector, beginning with a substantial reduction in red tape.
February 26, 2025 04:31 PM AEDT| By Team Kalkine MediaHighlights,Political debates intensify over mining policies ahead of WA elections.,Proposed reforms could impact regulations, land access, and labor markets.,Industry stakeholders watch closely as policies evolve.,The mining and resources sector is a...
Recce Pharmaceuticals Expands Global Reach with Japanese Patent Approval
February 26, 2025 01:59 PM AEDT| By Team Kalkine MediaHighlights,Recce Pharmaceuticals (RCE) secures a new patent in Japan, extending protection until 2041.,Japan’s pharmaceutical market ranks third globally, with rising demand for anti-infective therapies.,Patent covers RECCE® 327 and RECCE® 529, targe...
Sonic Healthcare's (ASX:SHL) First Half 2025 Results Show Steady Growth and Margin Expansion
February 26, 2025 01:53 PM AEDT| By Team Kalkine MediaHighlights,Revenue reaches AU$4.67 billion, marking an 8.4% increase year-over-year.,Net income rises 17% to AU$236.7 million, improving profit margins.,Revenue growth projections align with industry trends in Australia.,f 2025, demonstrating steady...
PolyNovo (ASX:PNV) Reports First Half 2025 Financial Results
February 26, 2025 01:39 PM AEDT| By Team Kalkine MediaHighlights,Revenue increases by 26% compared to 1H 2024,Profit margin slightly decreases to 5.6%,EPS improves from AU$0.004 to AU$0.005,PolyNovo (,ASX:PNV,) has released its first half 2025 financial results, showcasing a strong growth in revenues. T...
Patrys First Half 2025 Earnings Report: Loss of AU$0.001 per share, consistent with the AU$0.001 loss in the first half of 2024.
February 26, 2025 01:32 PM AEDT| By Team Kalkine MediaHighlights:,Revenue experienced an increase compared to the same period last year,Net loss showed a notable decline, reflecting improved financial performance,Shares experienced an upward trend over the past week,Patrys Limited (ASX:PAB),, operating...
AI platform Decidr partners with Go1 to enhance corporate learning
February 26, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Decidr Industries (ASX:DAI) partners with Go1 to enhance AI-driven career development solutions.,The partnership aims to integrate Decidr’s AI technology into Go1’s extensive learning platform, offering customized upskilling and career pat...
Regis Healthcare Limited: Sustained Growth and Market Performance
February 25, 2025 03:30 PM AEDT| By Team Kalkine MediaHighlights:,Consistent Revenue Expansion:,Growth trends play a crucial role in shaping market valuation.,Dividend Impact on Returns:,Shareholder returns are significantly influenced by dividend distributions.,Market Performance Trends:,Share price mo...
Steady Dividend Growth: Sonic Healthcare (ASX:SHL) Enhances Shareholder Returns
February 25, 2025 01:58 PM AEDT| By Team Kalkine MediaHighlights,Sonic Healthcare (SHL) to distribute a dividend of A$0.44 per share.,Attractive,yield of 3.8% enhances shareholder returns.,Consistent 10-year history of steady dividend growth.,Sonic Healthcare (ASX:SHL) has announced an upcoming dividend...
Earnings Surge and Valuation Concerns: A Closer Look at PolyNovo’s Performance
February 25, 2025 01:56 PM AEDT| By Team Kalkine MediaHighlights,PolyNovo,(,ASX:PNOV,) shares,drop,14.7% in early trading.,First-half results show a,strong,increase in net profit and revenue.,Revised forecasts reflect challenges from currency and market pressures.,PolyNovo (ASX:PNOV), a leading medical...
Cryosite's First Half 2025 Financials: A Detailed Look
February 25, 2025 01:37 PM AEDT| By Team Kalkine MediaHighlights,Cryosite's revenue rises 3.7% to AU$6.64m.,Net income remains steady at AU$838.0k.,Shares increase by 14% in the past week.,The recent financial release by Cryosite (ASX:CTE) for the first half of 2025 reveals a 3.7% increase in revenue, a...
Nanosonics Limited (ASX:NAN): A Closer Look at Recent Stock Activity
February 25, 2025 01:37 PM AEDT| By Team Kalkine MediaHighlights,Nanosonics shares surge 26% in the past month,The company's P/S ratio stands at 7.7x, above industry norms,Future revenue growth aligns closely with industry expectations,Nanosonics Limited, with the ticker (ASX:NAN), has experienced a rem...
Firebrick Pharma (ASX:FRE) First Half 2025 Financial Overview
February 25, 2025 01:33 PM AEDT| By Team Kalkine MediaHighlights,Significant revenue drop to AU$197.1k from 1H 2024.,Net loss increased by 61% from the previous year.,Shares gained a slight increase over the past week.,The financial landscape of Firebrick Pharma (ASX:FRE) for the First Half of 2025 reve...
Cambium sees a 43% surge following FDA approval for Phase 3 trial of Elate Ocular.
February 25, 2025 12:30 PM AEDT| By Team Kalkine MediaHighlights,FDA-approved Phase 3 trial for an innovative ocular therapy.,Nearly 800 participants enrolled across multiple countries.,Potential to transform treatment for moderate to severe dry eye disease.,In the competitive landscape of biotechnology...
Next Science's stock drops following an FDA warning letter suggesting that their product might have led to injuries.
February 25, 2025 12:30 PM AEDT| By Team Kalkine MediaHighlights,FDA warning led to a 13% drop in Next Science shares.,Quality system and reporting issues were identified.,Misleading marketing practices raised compliance concerns.,The biotechnology sector is a dynamic and innovative industry, focused on...
Aroa's Sheep-Derived Products Reach Milestone with Seven Million Medical Uses
February 25, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,Aroa Biosurgery’s soft-tissue regeneration products have been used in medical procedures worldwide, surpassing a major usage milestone.,The company’s extracellular matrix technology, derived from New Zealand sheep rumen, continues to advan...
EZZ Life Science Expands into US Market with Key Manufacturing Deal
February 25, 2025 11:00 AM AEDT| By Team Kalkine MediaHighlights,EZZ Life Science enters agreement with GLSP Inc to manufacture dietary supplements in the US, aligning with FDA and ISO-certified standards.,The partnership facilitates EZZ's plan for US market entry in H2 FY25, ensuring improved productio...
Advertise your brand on Kalkine Media